@article{ajmcr20219910,
author={{Giuliano, Alessandra and Mandreucci, Francesca and Benfante, Alida and Cicero, Maria Noemi and Seminara, Gabriele and Scichilone, Nicola and Carroccio, Antonio and Bruno, Erica Maria and Castellucci, Daniele and Chiavetta, Marta and Compagnoni, Stella and Monachino, Noemi and Teresi, Giulia and Martorana, Giuseppe and Maisano, Simonetta},
title={Resolution of Chronic Eosinophilic Pneumonia during Treatment with Benralizumab in Patient with Peripheric Blood Eosinophilia},
journal={American Journal of Medical Case Reports},
volume={9},
number={9},
pages={482--484},
year={2021},
url={http://pubs.sciepub.com/ajmcr/9/9/10},
issn={2374-216X},
abstract={Chronic eosinophilic pneumonia is a rare idiopathic form of pneumonia. A differential diagnosis is crucial to distinguish idiopathic from secondary forms and it requires clinical, laboratory and imaging investigations. In this case report we present a case of Chronic eosinophilic pneumonia and discuss differential diagnosis in a patient with a history of uncontrolled chronic asthma and moderate peripheral eosinophilia. Benralizumab, an anti-Interleukin-5 receptor drug, was administered to our patient, who remained asymptomatic throughout a ten-month follow-up. Further studies are essential to confirm the favorable effect of this novel therapy for Chronic eosinophilic pneumonia.},
doi={10.12691/ajmcr-9-9-10}
publisher={Science and Education Publishing}
}